These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1026366

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I, Rosenthal J.
    Dtsch Med Wochenschr; 1978 Nov 10; 103(45):1790-6. PubMed ID: 710289
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Angiotensin II blockade: evidence for baroreceptor-mediated renin release and the role of sodium balance.
    Baer L, Parra-Carrillo JZ, Radichevich I.
    Kidney Int Suppl; 1979 Mar 10; (9):S60-7. PubMed ID: 289865
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M, Passalacqua W, Plaza de los Reyes X, Pla C, Campino C.
    Rev Med Chil; 1980 Feb 10; 108(2):115-20. PubMed ID: 7017869
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH, Bönner G, Gram N, Mann JF, Helber A, Ganten D.
    Klin Wochenschr; 1978 Feb 10; 56 Suppl 1():97-105. PubMed ID: 732257
    [Abstract] [Full Text] [Related]

  • 33. Failure of saralasin to predict a response to surgery in renovascular hypertension.
    Thomas RD, Ball SG, Lee MR.
    Lancet; 1977 Apr 02; 1(8014):724-6. PubMed ID: 66520
    [Abstract] [Full Text] [Related]

  • 34. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J, Liebau G, Steiner B, Hayduk K.
    Klin Wochenschr; 1978 Sep 01; 56(17):859-64. PubMed ID: 713415
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Incidence and pathophysiological changes in chronic two-kidney hypertension in the dog.
    Watkins BE, Davis JO, Hanson RC, Lohmeier TE, Freeman RH.
    Am J Physiol; 1976 Sep 01; 231(3):954-60. PubMed ID: 970479
    [Abstract] [Full Text] [Related]

  • 37. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JI, White RP, Sealey JE, Laragh JH.
    Am J Med; 1976 Nov 01; 61(5):790-6. PubMed ID: 185903
    [Abstract] [Full Text] [Related]

  • 38. Renal hypertension.
    Fraley EE, Feldman BH.
    N Engl J Med; 1972 Sep 14; 287(11):550-2. PubMed ID: 4340496
    [No Abstract] [Full Text] [Related]

  • 39. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK, Williams GH.
    Kidney Int Suppl; 1979 Mar 14; (9):S29-35. PubMed ID: 384070
    [No Abstract] [Full Text] [Related]

  • 40. Reciprocation of renin dependency with sodium volume dependency in renal hypertension.
    Gavras H, Brunner HR, Thurston H, Laragh JH.
    Science; 1975 Jun 27; 188(4195):1316-7. PubMed ID: 1145199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.